New Clinical Trials for Irritable Bowel Syndrome (IBS)

Enroll in a Clinical Trial for Irritable Bowel SyndromeIf you suffer from irritable bowel syndrome chances are you spend many days being uncomfortable and missing work because of your condition. Although there is a large body of irritable bowel syndrome clinical research, not much is known about the disease.

While some suspect it is the result of a yet to be discovered infection others believe there is a mind/body connection. There is no known cause, no clear diagnosis method and no cure. There are ongoing irritable bowel syndrome clinical trials being conducted. 

What is Irritable Bowel Syndrome (IBS)?

Irritable bowel syndrome (IBS) is also sometimes called spastic colon. Irritable bowel syndrome is diagnosed when no specific cause can be found for a condition that involves chronic pain in the abdomen, bloating and abnormal bowel habits. There are several classifications of IBS – constipation predominant (IBS-C), diarrhea predominant (IBS-D) and alternating between the two (IBS-A). The cause of irritable bowel syndrome is not known. Some believe it is a disorder where the brain and the gastrointestinal tract have trouble communicating. Others believe it is a psychological disease resulting from stress.

Irritable Bowel Syndrome (IBS) Treatments

Irritable bowel syndrome was first documented as such around 1950. Many tests have been done on diet and how this might affect a person suffering from IBS. In some patients restricting their diet of lactose or fructose has helped in treating irritable bowel syndrome. Taking in more soluble fiber has also proven effective. Depending on the type of IBS different medications like laxatives or antispasmodics can be prescribed. Psychotherapy including cognitive behavior therapy and hypnosis has been effective in treating irritable bowel syndrome. As a last resort for the treatment of irritable bowel syndrome tricyclic antidepressants are sometimes prescribed.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
881 Irritable Bowel Syndrome (IBS)
clinical trials

Gastroenterology Clinical Trial
Irritable Bowel Syndrome (IBS) Clinical Trial
Status: Upcoming
mi
from
DeLand, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Kingsport, TN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Tampa, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Castle Rock, CO
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Dayton, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Encinitas, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Huntsville, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Laurel, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Longview, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Mobile, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Paw Paw, MI
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Neurology, Rheumatology Clinical Trial
Observational Study of Control Participants for the MAPP Research Network
Status: Enrolling
Updated: 5/14/2013
mi
from
St Louis, MO
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
mi
from
Anaheim, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
mi
from
Boise, ID
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
mi
from
Norman, OK
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
mi
from
Waterbury, CT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Columbus, OH
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
mi
from
Hershey, PA
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling, Phase II
Updated: 12/13/2013
mi
from
San Antonio, TX
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling, Phase II
Updated: 12/13/2013
mi
from
St. Louis, MO
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Gut Permeability, Sensitivity and Symptomatology
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
mi
from
Rochester, MN
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Wichita, KS
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Charleston, SC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Corona, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Morristown, NJ
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Smithfield, PA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Waxahachie, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Corticosteroid Dosage for Crohn's Disease Flare
Status: Enrolling, Phase IV
Updated: 1/5/2018
mi
from
New Haven, CT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Analyzing IBS to Identify Biomarkers and Microbiome Signatures
Status: Enrolling, Phase
Updated: 1/12/2016
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Beaumont, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Jackson, MS
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Orange, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
San Antonio, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Sandy, UT
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
mi
from
Wyoming, MI
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Denver, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Musculoskeletal, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
Status: Enrolling
Updated: 1/10/2018
mi
from
Burlington, VT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
mi
from
Kansas City, MO
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
mi
from
Norfolk, VA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
mi
from
Little Rock, AR
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Inflammatory Bowel Diseases Clinical Trial
IBD Shared Decision Making Intervention
Status: Enrolling
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Iowa City, IA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Madison, WI
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Winston-salem, NC
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Laredo, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Nicholasville, KY
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms
Status: Enrolling
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Diet Reintroduction Study in Irritable Bowel Syndrome
Status: Enrolling
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Endpoint Determination Study Protocol
Status: Enrolling
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Carbondale, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Carthage, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Centralia, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Effingham, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Grand Island, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Helena, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Kalispell, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Kearney, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lakewood, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Littleton, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Louisville, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Louisville, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Missoula, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Missoula, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New Orleans, LA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New Ulm, MN
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9